Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)continues to file a series of patent infringement lawsuits against various company as it seeks to protect its products from generic competition. It goes without saying that some of these cases result in unnecessary expenses, prompting companies to opt for early settlement as it removes uncertainty regarding timing of generic product launches, as well as considerably reducing litigation costs. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) net profit margin is 6.80% and weekly performance is -1.37%. On last trading day company shares ended up $52.45. Analysts mean target price for the company is $57.09. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) distance from 50-day simple moving average is 3.44%.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced it has earned a $10 million milestone payment from Biogen Idec Inc (NASDAQ:BIIB) associated with the validation of an undisclosed target to treat a neurological disorder. This is the first milestone payment under Isis’ and Biogen Idec’s 2013 strategic collaboration to advance the treatment of neurological disorders. This collaboration combines Biogen Idec’s expertise in neurology with Isis’ leadership in antisense technology to develop novel therapies to treat neurological disorders and is the fourth collaboration between the two companies.
Biogen Idec Inc (NASDAQ:BIIB) shares advanced 1.23% in last trading session and ended the day on $318.63. BIIB Gross Margin is 86.90% and its return on assets is 16.60%. Biogen Idec Inc (NASDAQ:BIIB) quarterly performance is 2.86%.
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, and QLT Inc. (NASDAQ: QLTI) (TSX: QLT), a Canadian-based biotechnology company focused on developing innovative orphan ophthalmology products, announced that they have entered into a definitive agreement under which Auxilium plans to merge with QLT. The transaction is expected to drive shareholder value creation by accelerating Auxilium’s ongoing transformation into a leading diversified North American specialty biopharmaceutical company. As a result of the merger, Auxilium expects to have an expanded corporate platform that includes focused investments in research and development and the continued pursuit of new products and M&A due to cost and tax synergies. The companies also intend to continue to pursue a potential partnering agreement for QLT’s promising late-stage retinoid program. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shares moved down -2.54% in last trading session and was closed at $20.69, while trading in range of $20.26-$21.83. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) year to date performance is -0.19%.
Cliffs Natural Resources Inc (NYSE:CLF) today issued a letter to shareholders in connection with its upcoming 2014 Annual Meeting of Shareholders scheduled to be held on July 29, 2014.Cliffs Natural Resources Inc (NYSE:CLF) ended the last trading day at $15.02. Company weekly volatility is calculated as 4.35% and price to cash ratio as 6.32. Cliffs Natural Resources Inc (NYSE:CLF) showed a positive weekly performance of 1.76%.
Glu Mobile, Inc. (Nasdaq: GLUU) announced support for Google’s Android TV platform. Glu’s Deer Hunter® 2014 and Eternity Warriors 2 are available immediately on the platform with additional support in development.Glu Mobile Inc. (NASDAQ:GLUU) net profit margin is -11.40% and weekly performance is 14.10%. On last trading day company shares ended up $4.45. Analysts mean target price for the company is $5.76. Glu Mobile Inc. (NASDAQ:GLUU) distance from 50-day simple moving average is 14.29%.